DanCann Pharma A/S: The US will enable more research into medical cannabis
COPENHAGEN, Denmark, 12 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby comments on new legislation in the USA which will increase the possibilities to enable further research in medical cannabis.Last week, US President Joe Biden signed a law that will make it possible to investigate in the potential uses of cannabis to a greater extent. So far, cannabis in the USA is categorized at federal level as a so-called category 1 substance. The new legislation will open for more research and information. After